Crossmark

Effectiveness and safety of the MiniMed™ 780G in newly diagnosed adolescents with type 1 diabetes: an observational real-world study

Published Online: 2026-05-04

Authors

Mameli, Chiara

Sodero, Roberta

Gaudenzi, Francesca

Redaelli, Francesca Chiara

Hajro, Adelina

Petitti, Agnese

Lauriola, Federico

Panero, Benedetta

Ippoliti, Anna

Chiarelli, Francesco

Zuccotti, Gianvincenzo
License Information

Text and Data Mining valid from 2026-05-04

Version of Record valid from 2026-05-04
More Information

Article History

Received: 17 February 2026

Accepted: 12 April 2026

First Online: 4 May 2026

Declarations

:

: This study received ethical approval of ASST FBF SACCO Ethics Committee no. 0048143/2023.

: all the authors gave their consent for publication.

: The authors declare no competing interests.

Document is current